Building

1
Building Implementing a Global Vision for 2020

• Pharmaceuticals and Public Health

Dr Kamal K Midha FIP President
2
Pharmaceuticals and Public Health
3
A Global FIP Vision for Health
122 Member Organizations in 87 Countries
4000 Individual Members in 160 Countries
Representing over 2 million pharmacists and
pharmaceutical scientists worldwide
4
2020 Vision FIPs Vision, Mission Strategic
Objectives
5
Mission
The Mission of FIP is to improve global health
by advancing pharmacy practice and science to
enable better discovery, development, access to
and safe use of appropriate, cost-effective
quality medicines worldwide.
mission
6
3 Strategic Objectives

• Advance pharmacy practice in all settings
• Advance the pharmaceutical sciences
• Increase FIPs role in reforming pharmacy and
  pharmaceutical sciences education

strategic objectives
7
Research Development of Pharmaceuticals

• FDA Drug Approvals

53
39
Number of new products
35
31
30
27
24
21
18
18
17
17
7
7
6
6
5
5
4
3
3
2
2
2
1996 1997 1998 1999 2000
2001 2002 2003 2004 2005
2006 2007
YEAR
Adapted from B.Hughes, 2008, Nature
Reviews/Drug Discovery, 7, 107-109
8
Pharmaceutical Sciences Planning for the
Future

• Pharmaceutical Sciences 2020
• Nearly 40 global leaders met together in October
  2008 in Amsterdam
• Various scenarios created for the future of
  pharmaceutical sciences and innovation.

Think the unthinkable!
9
Counterfeit medicines

• IMPACT
• FIP leads Working Group on Communication
• First IMPACT Global Forum, February 2008
• Intervention on counterfeit medicines at the
  World Health Assembly, May 2008

10
http//www.whpa.org/Toolkit_BeAware.pdf
11
Access to affordable medicines

• 2.7 billion - 43 of the world population, live
  on less than US 2 a day
• Medicines account for 2060 of health spending
  in developing and transitional countries - 18 in
  countries of the OECD
• Wholesale mark-ups range from 2 in Pakistan to
  380 in El Salvador
• Opportunities exist to increase availability,
  lower prices, and improve affordability of
  medicines in all regions and at all levels of
  country development.

Cameron et al. The Lancet. Dec 2008.
12
Affordability of medicines
13
Human Resources for Health
World Health Report Working Together for
Health. FIP report Global Pharmacy Workforce
and Migration
14
FIP-UNESCO-WHOPharmacy Education Action Plan
Now undertaking the 4th Global Pharmacy
consultation via an online community of practice
15
http//www.who.int/medicines/publications/WHO_PSM_
PAR_2006.5.pdf
16
Adherence to medicines

• The extent to which a persons behaviour
  taking medication, following a diet, and/or
  executing lifestyle changes, corresponds with
  agreed recommendations from a health care
  provider.

WHO 2003
17
FIP statement

• If patients are full partners with the health
  professionals involved in their care, in all
  decisions about taking medicines, they are more
  likely to follow the agreed regimen.

FIP 2003
18
Collaborative Pharmacy Practice
Level 5
Authority to initiate or modify medicine therapy
Degree of Collaboration
Amount of Responsibility
Level 4
Prospective advice and/or referral by another
healthcare professional
Level 3
Reactive advice to other healthcare professionals
Level 2
System wide authority to supply medicines
Level 1
Minimal contact between pharmacists and other
healthcare professionals
19
Collaborative Pharmacy Practice

• When pharmacists have a core place
  in the multi-disciplinary healthcare team,
  the outcomes, as per this report, are
• significantly improved patient care
• greater patient safety
• major economic savings to healthcare systems

20
A Global Vision for Health
www.fip.org